Result of AGM

Summary by AI BETAClose X

Severn Trent Plc announced that all 22 resolutions presented at its 2026 Annual General Meeting were duly passed by shareholders. Key resolutions included the approval of the Annual Report and Accounts for the year ended 31 March 2026 with 99.99% of votes for, the Directors' Remuneration Report with 98.62% for, and the declaration of a final ordinary dividend with 96.99% for. The re-election of directors and the reappointment of PricewaterhouseCoopers LLP as auditor also received strong support, with over 98% of votes in favour for most director re-elections and 99.98% for the auditor reappointment. Resolutions concerning the disapplication of pre-emption rights and the purchase of own shares also passed with significant majorities, indicating shareholder confidence.

Disclaimer*

Severn Trent PLC
09 July 2026
 

 

9 July 2026

 

Severn Trent Plc ("Severn Trent" or "the Company")

Results of the 2026 Annual General Meeting

 

 

The Company announces that the following resolutions were duly passed at the Company's 2026 Annual General Meeting ('AGM') which was held today at 10.00am at Severn Trent Academy, Garfield Park, St Martins Road, Finham, Coventry, CV3 6PR.

 

Resolutions 1 to 18 were passed as ordinary resolutions and resolutions 19 to 22 were passed as special resolutions.  Full text of the resolutions is contained in the Company's Notice of 2026 AGM, which is available at www.severntrent.com.

 

Resolution

Votes for

For (% of shares voted)

Votes against

Against (% of shares voted)

Total votes cast (excluding withheld)

% of issued share capital voted

Votes withheld

1

Receive the Annual Report and Accounts

for the year ended 31 March 2026

254,917,023

99.99

20,113

0.01

254,937,136

84.47

173,874

2

Approve the Directors' Remuneration Report

251,047,005

98.62

3,508,484

1.38

254,555,489

84.34

555,521

3

Approve the Directors' Remuneration Policy

250,588,888

98.25

4,460,544

1.75

255,049,432

84.51

61,578

4

Declare a final ordinary dividend in respect of the year ended 31 March 2026

247,398,125

96.99

7,682,516

3.01

255,080,641

84.52

30,369

5

Re-elect Christine Hodgson CBE

250,739,779

98.30

4,324,912

1.70

255,064,691

84.51

46,319

6

Elect James Jesic

254,115,234

99.63

945,552

0.37

255,060,786

84.51

50,224

7

Re-elect Helen Miles

253,872,824

99.53

1,189,587

0.47

255,062,411

84.51

48,599

8

Re-elect Nick Hampton

252,400,288

98.96

2,661,275

1.04

255,061,563

84.51

49,447

9

Re-elect Tom Delay CBE

251,881,316

98.75

3,181,033

1.25

255,062,349

84.51

48,661

10

Re-elect Sarah Legg

252,393,252

98.95

2,669,060

1.05

255,062,312

84.51

48,698

11

Re-elect Sharmila Nebhrajani OBE

252,416,858

98.96

2,647,406

1.04

255,064,264

84.51

46,746

12

Re-elect Richard Taylor

252,437,972

98.97

2,624,172

1.03

255,062,144

84.51

48,866

13

Reappoint PricewaterhouseCoopers LLP as Auditor of the Company

255,018,907

99.98

53,007

0.02

255,071,914

84.52

39,096

14

Authorise the Audit and Risk Committee to determine the remuneration of the Auditor

252,460,045

98.98

2,605,914

1.02

255,065,959

84.51

45,051

15

Authorise the Company to make

political donations

215,865,755

98.43

3,445,060

1.57

219,310,815

72.67

35,800,195

16

Approve the amendments to the rules of the

Severn Trent Plc Long Term Incentive Plan

252,701,911

99.08

2,344,082

0.92

255,045,993

84.51

65,017

17

Approve the amendments to the rules of

the Severn Trent Plc Sharesave Scheme

254,967,304

99.97

86,448

0.03

255,053,752

84.51

57,258

18

Authorise the Directors to allot shares

242,137,921

94.93

12,932,655

5.07

255,070,576

84.52

40,434

19

Disapply pre-emption rights on up to ten per

cent of the issued share capital.

248,629,564

97.48

6,431,174

2.52

255,060,738

84.51

50,272

20

Disapply pre-emption rights on up to an

additional ten per cent of the issued share

capital in connection with an acquisition or

specified capital investment

235,478,161

92.32

19,582,982

7.68

255,061,143

84.51

49,867

21

Authorise the Company to purchase

its own shares

248,101,822

97.33

6,814,922

2.67

254,916,744

84.46

194,266

22

Authorise the Directors to hold general

meetings on 14 clear days' notice

244,470,302

95.84

10,607,866

4.16

255,078,168

84.52

32,842

 

1.   Any proxy appointments which gave discretion to the Chair have been included in the "for" total.

 

2.   A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "for" and "against" a resolution.

 

3.   For the purposes of section 341 of the Companies Act 2006, as at 6:30pm (BST) on Wednesday 8 July 2026, the Company's issued share capital consists of 304,022,108 ordinary shares of 97 17/19 pence each with voting rights. The Company holds 2,218,618 shares in Treasury.

 

 

As required by the UK Listing Rule 6.4.2R of the Financial Conduct Authority ("FCA"), copies of resolutions passed by the Company other than resolutions concerning ordinary business have been submitted to the FCA via the National Storage Mechanism and will shortly be available to the public for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

www.severntrent.com

LEI: 213800RPBXRETY4A4C59

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Severn Trent (SVT)
UK 100

Latest directors dealings